WASHINGTON DC (March 30, 2020) — The US Food and Drug Administration has been providing unprecedented flexibility to labs and manufacturers to develop and offer COVID-19 tests across the US. The FDA’s regulations have not hindered or been a roadblock to the rollout of tests during this pandemic.







